Kinase, ion channel, and nuclear receptor subsets selected from novel compound designs using a ligand-based, pharmacaphore query based on known actives against each target family.
Kinase, ion channel, and nuclear receptor subsets selected from novel compound designs using a ligand-based, pharmacaphore query based on known actives against each target family.